Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T18:11:49.890Z Has data issue: false hasContentIssue false
  • English
  • Français

Tratamiento psicofarmacológico de la manía

Published online by Cambridge University Press:  12 May 2020

R. de Arce Cordón
R. de Arce Cordón*
Affiliation:
Hospital Universitario Puerta de Hierro, Madrid
Get access

Extract

Desde la introducción del litio en el tratamiento de la mania tras los trabajos ya clásicos de Cade y Schuo en los años 50, se ha acumulado un importante cuerpo de pruebas acerca de su eficacia tanto en el tratamiento de la manía aguda como en la profilaxis del trastorno bipolar, siendo considerado este fármaco de primera elección en la patología citada. Numerosos autores y revisiones Maj, Licth, Fieve, Bowden, Mc Elroy apoyan esta afirmación.

Type
Sección Española
Information
European Psychiatry (Ed. Española) , Volume 10 , Issue 7 , October 2003 , pp. 467 - 473
Copyright
Copyright © European Psychiatric Association 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Ponencia presentada en la “Reunión de Expertos sobre el uso de eutimizantes en Psiquiatría”

References

Bibliografía

Cade, JFJ, Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 14: 349–352.CrossRefGoogle Scholar
Schou, M, Juel-Nielsen, N, Stromgren, E, Voldby, H.The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17: 250–260.CrossRefGoogle ScholarPubMed
Maj, M.The impact of litium prophylaxis on the course of bipolar disorder. Bipolar Disorder 2000; 2: 93–101.CrossRefGoogle Scholar
Licth, RW.Prug treatment of manía: a critical review. Act Psychiatr Scand 1998; 97: 387–397.Google Scholar
Fieve, RR.Lithium therapy at the millenium: a rcvolutionary drug used for 50 years faces competing options and possible demise. Bipolar disorder 1999; 2: 67–70.CrossRefGoogle Scholar
Bowden, CL.Efficacy of lithium in mania and maintenance therapy of bipolar disorder. J Clin Psychitry 2000; 61 (suppl 9): 35–10.Google ScholarPubMed
Me, Elroy SL, Keck, PE.Pharmacologic agents for the treatment of acute bipolar mania. Bíol Psychiatry 2000; 48: 539–557.Google Scholar
Cookson, J.Use of antisychotic drugs and litium in mania. British J Psychiatry 2001; 178 (suppl 41) sl48–sl56.CrossRefGoogle Scholar
APA Practice guideline for the treatment of patients with bipolar disorder. American Journal Psychiatry, 151 (suppl 12) 1-36.CrossRefGoogle Scholar
Chou, JCY, Zito, JM et al.Neuroleptics in acute manía: a pharmacoepidemiology study. Ann Pharmacother 1996; 20: 1396–1398.CrossRefGoogle Scholar
Tohen, bipolar disorders del 2000.Google Scholar
Maggs, R.Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963; 109: 56–65.CrossRefGoogle Scholar
Goodwin, IK, Murphy, DL, Bunney, WE Jr.Lithium Carbonate treatment in depresión and mania: a longitudinal double-blind study. Arch Gen Psychiatry 1969; 21: 486–496.CrossRefGoogle Scholar
Stokes, PE, Shamoian, CA, Stoll, PMet al.Efficacy of lithium as acute treatment of manic-dcprcssive illness. Lancet 1971; 1: 1319–1325.CrossRefGoogle ScholarPubMed
Bowden, CL, Brugger, AM, Swann, AC, et al.Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271: 918–924.CrossRefGoogle ScholarPubMed
Johson, G, Gershon, S, Hckimian, LControlled evaluation of li thium and chlorpromazine in the treatment of manic states: An interim report. Compr Psychiatry 1968; 9: 563–573.CrossRefGoogle Scholar
Platman, SR.A comparíson of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970; 127: 351–353.CrossRefGoogle ScholarPubMed
Spring, G, Schweid, D, Gray, C, Steinbeig, J, Horwitz, M.A doble- blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970; 126: 1306–1310.CrossRefGoogle Scholar
Johson, G, Gerson, S, Burdock, El, Floid, A, Hekimian, IXComparative effeets of lithium and chlorpromazine in the treatment of acute manic states. Br JPsychiatry 1971; 119: 267–276.CrossRefGoogle Scholar
Prien, RF, Caffey, EF JR, Klett, CJ.Comparíson of lithium carbonate and Chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Arch Gen Psychiatry 1972; 26: 146–153.Google ScholarPubMed
Shopsin, B, Gerson, S, Thompson, H, Collins, P.Psychoactive drugs in mania: A controlled comparíson of lithium carbonate, chlorpromazine and haloperidol. Arch Gen Psychiatry 1975; 32: 34–42.CrossRefGoogle ScholarPubMed
Takahashi, R, Sakuma, A, Itoh, K, Kurihara, M, Saito, M, Watanabe, M.Comparíson of efficacy of lithium carbonate and chlorpromazine in manía: Report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 1975; 32: 1310–1318.CrossRefGoogle Scholar
Garfinkel, PE, Stancer, HC, Persad, E.A comparíson of haloperidol lithium carbonate and their combinatíon in the treatment of manía. J Affect Disord 1980; 2: 279–288.CrossRefGoogle ScholarPubMed
Segal, J, Berk, M, Brook, S.Risperidone compared with both li thium and haloperidol in mania: A doble blind randomized controlled trial. ClinNeuropharmacol 1998; 21: 176–180.Google Scholar
Janicak, PG, Newman, RH, Davis, JM.Advances in the treatment of mania and related disorders: a reappraisal. Psychiatric Annals 1992; 22: 92–103.CrossRefGoogle Scholar
Pope, HG, McElroy, L, Keck, PE, Hudson, JI.Valproate in the Treatment of Acute Mania. Arch Gen Psychiatry 1991;48:62–68.CrossRefGoogle ScholarPubMed
Freeman, TW, Clothier, JL, Pazzaglia, P, Lesem, MD, Swann, AC.A doble blind comparíson of valproato and lithium in the treatment of acute manía. Am JPsychiatry 149:108–111.Google Scholar
Muller-Oerlinghausen, B, Retzow, A, Henn, FA, Giedke, H, Walden, J.The European Valproate) Mania Study Group. Valproate) as an adjunct to neuroleptic medication for the treatment of acutes episodes of manía: A prospective, randomized, doble-blind, placebo-controlled multicenter study. J Clin Psychopharmacol 2000; 20: 195–203.Google ScholarPubMed
Freeman, MP, StoU, AL.Mood stabilizer combínations: a review of safety and efficacy. Am J Psychiatry 1998; 155: 12–21.CrossRefGoogle ScholarPubMed
Keck, PE, McElroy, SL, Bennett, JA.Pharmacological loading in the treatment of acute mania. Bipolar Disorder 2000; 2: 46–42.CrossRefGoogle Scholar
Keck, PE Jr, Strakowski, SM, Hawkins, JM, Dunayevich, Eet al.A pilot study of rapid lithium administration in the treatment of acute mania. Bipolar Disorder 2001; 3: 68–72.CrossRefGoogle ScholarPubMed
Lerer, B, Moore, N, Meyendorff, E, Cho, S-R, Gershon, S.Carbamacepina versus lithium in mania: A doble-blind study. J Clin Psychiatry 1987;48:89–93.Google Scholar
Small, JG, Klapper, MH, Milstein, V, Kellans, JJ, Miller, MJ, Marhenke, JD, Small, IF.Carbamacepine compared with Lithium in the treatment of mania. Arch Gen Psychiatry 1991; 48: 915–921.CrossRefGoogle Scholar
Okuma, T, Inanaga, K, Otsuki, S, Sarai, K, Takahashi, R, Itazama, H.Comparíson of the antímanic efficacy of carbacepine and chlorpromazine: a doble-blind controlled study. Psychopharmacology 1979; 66: 211–217.CrossRefGoogle Scholar
Grossi, E, Sachetti, E, Vita, A, Conte, G, Faravelli, C, Hautman, Get al.Carbamacepine versus chlorpromazine in mania: doble-blind trial. In: Emrich, HM, Okuma, T, Miiller, AA, editors. Anticonvulsants in Affective Disorders. Amsterdam: Excerpta Medica, 1984; 177–187.Google Scholar
Ballenger, JC, Post, RM.Terapeutics effects of carbamazepine in affective illness: A preliminary report. Commun Psychopharmacol 1978; 2: 159–175.Google Scholar
Post, RM, Ballenger, JC, Uhde, TW, Joffe, RT.Efficacy of carbamazepine in manic-depressive illness: Implications for underlying mechanisms. In Post, RM editor. Neurobiology of Mood Disorders. Baltimore: Williams and Wilkins, 1984;777–816.Google Scholar
Post, RM, Uhde, TW, Roy-Byrne, PP, Joffe, RT.Correlates of antimanic response to carbamazepine. Psychiatry Res 1987; 21: 71–83.CrossRefGoogle ScholarPubMed
De, León OA.Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder. Harvard Rev Psychiatry 2001; 9: 209–222.Google Scholar
Okuma, T.Effects of carbamazepine and lithium on affective disorders. Neurospychobiology 1993; 27: 138–145.Google ScholarPubMed
Miiller, AA, Stoll, KD.Carbamazepine and oxcarbazepine in the treatment of manic syndromes: Studies in Germany in Anticonvulsants in affective disorders. Emrich, HM, Okuma, T, Miiller, AA, eds. 1984 Elsevier Science Publishcrs BV.Google Scholar
Emrich, HM, Dose, M, von, Zerssen D.The use of sodium valproato, car-mamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 1985; 8: 243–250.CrossRefGoogle Scholar
Emrich, HM.Studies with oxcarbazepine in acute mania. Int Clin Psychopharmacol 1990; 5 (Suppl 1): 83–88.Google Scholar
Dietrich, DE, Kroop, H, Emrich, HM.Oxcarbazepine in affective and schizoaffective disorders. Pharmacopsychiatry 2001; 34: 242–252.CrossRefGoogle ScholarPubMed
Ichim, L, Berk, M y Brook S.Lamotrigine compared with Lithium in mania: a doble-blind randomized controlled trial. Annals Clin Psychiatry 2000;12 (1):5–10.CrossRefGoogle Scholar
Berk, M.Lamotrigine and the treatment of mania in bipolar disorder. European Neuropsychopharmacology 1999; 9 (suppl 4) S119–S124.CrossRefGoogle ScholarPubMed
Pande, AC, Crockatt, JG, Janney, CA, Werth, JL, Tsaroucha, G.Gabapentine in bipolar disorder: A placebo-controlled trial of adjuntive therapy. Bipolar Disorder 2000; 2: 249–255.CrossRefGoogle Scholar
Frye, MA, Ketter, TA, et al.A placebo- controlled study of lamotrigine and gabapentine monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20: 607–614.CrossRefGoogle ScholarPubMed
Grunze, H, Erfurth, A, Marcuse, A, Amann, B, Normánn, C, Walden, J.Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry 1999; 60: 759–762.CrossRefGoogle Scholar
Calabrese, JR, Keck, PE Jr, McElroy, SL, Werkner, JE.Topiramate in severe treatment-refractory mania. Presented at the 151st Annual Meeting of the American Psychiatric Association, Washington DC, May 1999.Google Scholar
McElroy, SL, Suppes, T, Keck, TE Jr, Frye, MA, Denicoff, KD, Altshuler, LL.Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000; 47: 1025–1053.CrossRefGoogle ScholarPubMed
Roy, Chengappa KN, Rathore, D, Levine, J, Atzert, R, et al.Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999; 1: 42–53.Google Scholar
Johnstone, EC, Crow, TJ, Frith, CD, Owens, DGC, The Northwick park fun-cional psichosis study: diagnosis and treatment response. Lancet 1988;2:119-125CrossRefGoogle Scholar
Zarate, Ca Jr, Tohen, M, Banov, MD, et al.¿Is clozapine a mood Stabilizer? J Clin Psychiatry 1995; 56: 108–112.Google Scholar
Calabrese, JR, Kimmel, SE, Woyshville, MJ, et al.Clozapine for treatment refractory mania. Am J Psychiatry 1996; 153: 759–764.Google ScholarPubMed
Barbini, B, Scherillo, P, Benedetti, F, Crespi, G, et al.Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol 1997; 12: 109–112.CrossRefGoogle ScholarPubMed
Green, AI, Tohen, M, Patel, JK, et al.Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157: 982–986.CrossRefGoogle ScholarPubMed
Segal, J, Berk, M, Brook, S.Risperidone compared with lithium and haloe-ridol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998;21 (3):176–180.Google ScholarPubMed
Sachs, G.Risperidone Bipolar Study Group. Safety and efficacy of risperidone vs placebo as add-on therapy to mood stabilizers in the treatment in the treatment of manic phase of bipolar disorder. Presented at the 38th annual meeting of the American College of Neuropsychopharmacology. Dec 1999 Acapulco. México.Google Scholar
Vieta, E, Gastó, C, Colom, F, Martínez, A, et al.Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol 1998; 18: 172–174.CrossRefGoogle ScholarPubMed
Tohen, M, Sanger, TM, McElroy, SL, Tollefson, GD, Chengappa, et al.Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999;156;702–709.Google ScholarPubMed
Berk, M, Ichim, L, Brook, S.Olanzapine compared to lithium in mania: a doble-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339–343.CrossRefGoogle Scholar